Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price was down 3.9% during mid-day trading on Tuesday . The company traded as low as $20.02 and last traded at $20.46. Approximately 15,772 ...
周四,BMO Capital Markets对市值约6.2亿美元的生物技术公司Tourmaline Bio (NASDAQ:TRML)启动了覆盖,给予"优于大市"评级,目标价为50.00美元。该股目前交易价格为24.03美元,已吸引了分析师的强烈兴趣,共识目标价在每股49美元至74美元之间。根据 InvestingPro 分析,该公司的整体财务健康评分为2.55(满分5分),属于"良好"水平。
We've seen more insider selling than insider buying at Tourmaline Oil recently. In that time, insider William Kirker dumped CA$4.4m worth of shares. Meanwhile insiders bought CA$1.1m worth. Since the ...